Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review.
about
Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance systemCharacterization of chemically induced liver injuries using gene co-expression modulesCorticosteroids and transition to delirium in patients with acute lung injury.Body image dissatisfaction in patients with inflammatory bowel disease.Posterior Reversible Encephalopathy Syndrome due to High Dose Corticosteroids for an MS Relapse.Efficacy of short period, low dose oral prednisolone for the prevention of stricture after circumferential endoscopic submucosal dissection (ESD) for esophageal cancerExamining systemic steroid Use in older inflammatory bowel disease patients using hurdle models: a cohort studyComorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry.Outcome Preferences in Patients With Noninfectious Uveitis: Results of a Best-Worst Scaling Study.Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects.Adverse event burden, resource use, and costs associated with immunosuppressant medications for the treatment of systemic lupus erythematosus: a systematic literature review.Assessing relapse in multiple sclerosis questionnaire: results of a pilot study.Development of the Systemic Lupus Erythematosus Steroid Questionnaire (SSQ): a novel patient-reported outcome tool to assess the impact of oral steroid treatment.Implications of glucocorticoid therapy in idiopathic inflammatory myopathies.Practical guidelines for the use of steroid-sparing agents in the treatment of chronic pruritus.The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy.The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years?Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.Treatment of giant-cell arteritis, a literature review.Burden of systemic glucocorticoid-related complications in severe asthma.Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patients.Vaginal evisceration related to genital prolapse in premenopausal womanBurden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel.High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO).Health-related quality of life associated with systemic corticosteroids.The Ethics of Deprescribing in Older Adults.The impact of long-term systemic glucocorticoid use in severe asthma: A UK retrospective cohort analysis.Effectiveness of rehabilitation in multiple sclerosis relapse on fatigue, self-efficacy and physical activity.The effects of corticosteroids on cognitive flexibility and decision-making in women with lupus.Glucocorticoid Use in Patients With Systemic Lupus Erythematosus: Association Between Dose and Health Care Utilization and Costs.Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.Morbidity associated with oral corticosteroids in patients with severe asthma.Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis.Phytochemical Analysis by HPLC-HRESI-MS and Anti-Inflammatory Activity of Tabernaemontana catharinensis.Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study
P2860
Q28535919-C0137344-E55A-4501-845A-55537285E7ADQ28543001-44122D17-61A0-4164-8C92-43783A94E150Q33638917-F55925BF-FC00-4AAE-9747-4319347E0D00Q35216581-1DE8F554-4C61-4049-91B5-0F8AA3C5C89BQ35697597-4374EBDC-5640-4ABC-A59D-342D05E0EB2CQ35768474-9DF59E90-A726-44E6-951E-DD0EE0454E0EQ35862806-D6D2C486-B23C-4819-B5C3-49FE5CE53EB2Q35906666-0A1E32AC-88BE-4AA2-87FF-78DBF831864CQ36228580-0AF6ED40-391A-44B9-8DC1-C77E79C288E5Q36242209-7124F173-3A04-40F5-945C-DE5982DE604DQ36802101-A7E60C51-848F-4882-A954-00ECF84B61D8Q36915999-829D9EE5-E7F9-4792-9060-EF303F6F3F75Q37673352-8CD0F5EF-BFC5-477A-9FBC-15006E249F9FQ38017953-2D8FF63B-9EF8-43D3-AA90-C61E5F4230F0Q38095599-B26A3BF0-2882-46D4-8281-7E95F23833B2Q38436495-4EFC0A4F-D028-4403-8A0D-82FE225CAA97Q38608906-C366B080-BB66-41BE-A4AB-97CDDD06211AQ38780534-A1507587-1E41-4BD9-80AC-838103C5B47BQ39029638-022953F2-F5BE-4DBA-81D6-746CB86F86F1Q39391610-EFFB3D79-C966-4397-90F1-BE6627494321Q40046590-95ACAE24-A901-46B2-A3C1-997C7DFC7247Q40958410-0D37868E-0F72-4AA6-973F-AF2047C45667Q41412281-DE002006-321C-4B7B-B515-001EC4AA47CEQ44615394-84AB25CC-110B-45CA-B7A9-E556E994D167Q47282148-AD88508D-4EB2-466B-B715-20C9C64B7F72Q47640135-E132DCE7-FEDF-47AA-9E21-33390E28231AQ47698296-37BE8F46-6826-4EB6-A921-D187D9E09F08Q47769040-8784E40B-7EEC-4FFE-8DFF-0FE05D25CDEFQ47912586-57698095-450B-4C69-ABE9-93A47A57B5E7Q48058862-13A1783C-3D13-4325-85FC-A43AC4ECCD01Q49154421-16F844D9-4A55-491F-A5BC-B01B2F6EFEBFQ50052184-7B8AD691-3701-49CF-9683-15D053517725Q51545298-C5D5C60C-696B-4C21-B822-9FBAD98DFB7FQ54227322-62EC10D3-059E-4B2C-A603-87D19F552D49Q55031921-5AE928C5-D51B-47B5-95BE-CB682A8B4AB9Q58694343-9BABE85F-FA3C-4CA8-9C79-6DE6EE3007E9
P2860
Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Incidence and US costs of cort ...... systematic literature review.
@ast
Incidence and US costs of cort ...... systematic literature review.
@en
Incidence and US costs of cort ...... systematic literature review.
@nl
type
label
Incidence and US costs of cort ...... systematic literature review.
@ast
Incidence and US costs of cort ...... systematic literature review.
@en
Incidence and US costs of cort ...... systematic literature review.
@nl
prefLabel
Incidence and US costs of cort ...... systematic literature review.
@ast
Incidence and US costs of cort ...... systematic literature review.
@en
Incidence and US costs of cort ...... systematic literature review.
@nl
P2093
P1476
Incidence and US costs of cort ...... systematic literature review.
@en
P2093
Damon Bass
Evelyn Sarnes
Greg Dennis
Leslie Crofford
Maria Watson
P304
P356
10.1016/J.CLINTHERA.2011.09.009
P577
2011-10-13T00:00:00Z